Skip to main content

Novo Nordisk A/S B(NONOF)
OTC US

Today's Change
Delayed Last Update

Novo Nordisk A/S B

Sectors & Indices

Sector
Industry
Employees

    Profile

    Novo-Nordisk A/S was incorporated on 28th November, 1931 in Denmark. It is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments: diabetes care and biopharmaceuticals. The diabetes care segment covers insulins, GLP-1, other protein-related products which include glucagon, protein-related delivery systems and needles, obesity and oral antidiabetic drugs. The biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy, hormone replacement therapy and inflammation.

    Key Executives

    NameTitle
    Information not available.